Top 50 Pharma Tracker: eHCPs eager for updated COVID-19 vaccines following FDA decision

09.07.2024 | Tracker

Top 50 Pharma Tracker: eHCPs eager for updated COVID-19 vaccines following FDA decision

The Top 50 Pharmaceutical Companies mentioned by eHCPs on X

June
Rank
May
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer3,6284068
23Moderna2,01119813
34Johnson & Johnson1,0304196
42AstraZeneca57424911
56GSK5491329
617AbbVie47842520
712Gilead Sciences3811394
811Novavax3626414
95Novo Nordisk33818422
108Bayer264948
1115Lilly2411392
129Roche2385513
137Abbott22118710
1410Sanofi21110617
1518Takeda1951880
1619Merck & Co188801
1714Novartis16110610
1816Otsuka122150
1929Boehringer Ingelheim111680
2020BMS99822
2121Amgen85551
2226Organon6990
2324Fresenius51282
2427UCB43399
2530Daiichi Sankyo41272
2634Merck KGaA40366
2641Chugai4033
28#N/ASTADA Arneimittel3980
2922Regeneron36181
3039Vertex32272
3131Astellas30201
3235Teva28242
3238Jazz Pharmaceuticals28253
3444Incyte25221
3536Viatris2410
3628Biogen2190
3633Eisai21150
3637Bausch2130
3940CSL15122
4032Ipsen13102
4145Sun1290
4243Grifols1010
4323Servier850
4325Menarini860
45#N/ADr. Reddy's Labratories610
4650Jiangsu Hengrui400
5050Shanghai000
5050Sino000
50#N/AYunnan Baiyao Group000
50#N/AMitsubishi Chemical Group000

June’s insights from eHCPs mentioning the Top 50 Pharmaceutical Companies

The five most mentioned pharmaceutical companies by eHCPs on X in June 2024 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and GSK.

CREATION.co identified 10,430 eHCP mentions of pharmaceutical companies in June 2024, decreasing by 4.4% over the previous month.

On 06 June, eHCPs took to X to discuss the FDA decision to update the formula for vaccine manufacturers for new COVID-19 vaccines. Novavax responded with a message that they are “ready to help”. eHCPs have historically been very positive towards the data that Novavax’s vaccines have produced, and this trend continued in June.

Following this, on 15 June eHCPs shared a positive response to Novavax’s intentions to have vaccine doses ready by mid-July. Family doctor Noha Aboelata expressed how she “loves” Novavax’s decision to pre-fill the syringes for doctors.

Shared by 31 eHCPs

On 25 June, eight eHCPs shared a post by the American Society of Echocardiography regarding the latest academic poster for echocardiographic imaging. The poster was developed in collaboration with BMS.

Shared by 8 eHCPs

The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:

  1. An academic poster developed by American Society of Echocardiography in collaboration with BMS around Hypertrophic Cardiomyopathy imaging.
  2. A Novavax press release discussing the application for FDA approval of a new COVID-19 vaccine.
  3. An FDA article discussing updates to COVID-19 vaccines for manufacturers.

——

Find out how the conversation is changing in other Top 50 Trackers and new analysis of the online HCP conversation in a variety of topics

You can also receive these updates and more straight to your inbox by signing up to CREATION.co’s monthly eJournal.

 

Methodology notes:

  • In June 2024, CREATION Pinpoint® identified 10,430 posts on X (Twitter) from 4,417 individual eHCPs mentioning a Top 50 Pharmaceutical company (based on revenue). 
  • Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 30 June 2024.
  • Unless otherwise specified, mentions of a company are not limited to its X account(s).
  • In some cases, a post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In June 2024, 50 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.

Share this article

Meet the Author

Aman Jandu

With a background working in IT systems administration, and leveraging a 1st Class degree in Digital Technologies, Aman uses his technical skills to apply a systematic approach to gather data and analyse insights.

Aman loves to Speedcube. While he can currently solve a Rubik’s Cube in around 20 seconds, he is learning how to complete it blindfolded.

Suggested next


13.04.2022 | Article

Top 50 Pharma Tracker: HCPs compare immune responses of T cell, B cell, and Antibodies to different COVID-19 vaccines.

Conversations still largely revolved around vaccine efficacy, with HCPs sharing various...

By Francesca Gan and Chawanzi Chintu

10.01.2022 | Article

Product Launch Tracker: Pre-Christmas approvals drive HCPs conversations

Discover which new drug approvals dominated HCPs conversations pre-Christmas...

By Paul Cranston and Tomi Shobande

View all articles >